Table 1.
Characteristics of participants with and without injection-related hospitalization
| Total | IDU-hospitalization | Non-IDU hospitalization | P value | |
|---|---|---|---|---|
|
| ||||
| n (%) | 252 (100%) | 154 (61.1%) | 98 (38.0% | |
|
| ||||
| Age, mean (sd) | 37.9 (10.7) | 37.8 (10.4) | 38.2 (11.2) | 0.772 |
| Male, n (%) | 147 (58.3) | 94 (61.0) | 53 (54.1) | 0.276 |
| Race | ||||
| White, n (%) | 150 (59.5) | 94 (61.0) | 56 (57.1) | |
| Black, n (%) | 52 (20.6) | 27 (17.5) | 25 (25.5) | |
| Other, n (%) | 50 (19.8) | 33 (21.4) | 17 (17.3) | 0.286 |
| Latinx, n (%) | 40 (15.9) | 31 (20.1) | 9 (9.2) | 0.020 |
| Nights Homeless | 18.6 (37.0) | 15.7 (33.7) | 23.2 (41.4) | 0.115 |
| MOUD in past 30 days, n (%) | 68 (27.0%) | 41 (26.6) | 27 (27.6) | 0.872 |
| Infections in past year, mean (sd)a | 1.6 (2.35) | 2.0 (2.5) | 0.9 (2.0) | 0.000 |
| HIV+ | 32 (12.7) | 23 (14.9) | 9 (9.2) | 0.181 |
| Stimulant use, n (%) | 205 (81.3) | 127 (82.5) | 78 (79.6) | 0.729 |
| SOWSb | 3.7 (1.7) | 3.7 (1.72) | 3.64 (1.69) | 0.780 |
***
p<.001
**
p<.01
*
p<.05
a
Skin and soft tissue infections in past year
b
SOWS was only assessed in individuals who reported opioid withdrawal symptoms. Those who reported no opioid withdrawal symptoms were not assessed with SOWS. These individuals were assigned a SOWS score of 0.